Recommendations for appropriate serum electrophoresis requests: The Italian approach

Clinical Chemistry and Laboratory Medicine

Volumn 51, Issue 6, 2013, Pages

  Graziani, Maria Stella ^b   Merlini, Giampaolo ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b NONE

Author keywords

Appropriateness; Monoclonal gammopathies; Serum electrophoresis

Indexed keywords

HOSPITAL ADMISSION; HUMAN; LETTER; MOLECULAR RECOGNITION; MONOCLONAL IMMUNOGLOBULINEMIA; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; PROTEIN ELECTROPHORESIS;

BLOOD PROTEINS; ELECTROPHORESIS; HUMANS;

EID: 84882292429     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2013-0010     Document Type: Letter

References (10)

1. McTaggart M, Kearney E. Evidence-based use of serum protein electrophoresis in laboratory medicine. Clin Chem Lab Med 2013;51:e113-e115.
2. Graziani MS, Dolci A, Greco C, Luraschi P, Muratore MT, Mussap M, et al. Indicazioni per la richiesta di elettroforesi proteica. Biochim Clin 2008;32:48-51.
3. Tsai DE, Acqui NA, Tomaszewski JE, Olthoff KM, Ahya VN, Kotloff RM, et al. Serum protein electrophoresis abnormalities in adult solid organ transplant patients with post-transplant lymphoproliferative disorders. Clin Transplant 2005;19:644-52.
4. Aguzzi F, Bergami MR, Gasparro C, Bellotti V, Merlini G. Occurrence of monoclonal components in general practice: clinical implications. Eur J Haematol 1992;48:192-5.
5. Kyle RA, Therneau TM, Rajkumar SV, Larson DR, Plevak MF, Offord JR, et al. Prevalence of monoclonal gammopathy of undetermined significance. N Engl J Med 2006;354:1362-9.
6. Therneau TM, Kyle RA, Melton J, Larson DR, Benson JT, Colby CL, et al. Incidence of monoclonal gammopathy of undetermined significance and estimation of duration before first clinical recognition. Mayo Clin Proc 2012;87:1071-9.
7. Landgren O, Kyle RA, Pfeiffer RM, Katzman JA, Caporaso NE, Hayes RB, et al. Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study. Blood 2009;113:5412-7.
8. Rajkumar SV. Prevention of progression in monoclonal pammopathy of undetermined significance. Clin Cancer Res 2009;15:5606-8.
9. Kyle RA, Durie BG, Rajkumar SV, Landgren O, Blade J, Merlini G, et al. International Myeloma Working Group. Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management. Leukemia 2010;24:1121-7.
10. Merlini G, Palladini G. Differential diagnosis of monoclonal gammopathy of undetermined significance. Hematology Am Soc Hematol Educ Program 2012;2012:595-60.